OrbiMed Partners II, L.P. recently submitted a Form D/A filing with the Securities and Exchange Commission. The significance of this filing lies in the fact that Form D is required to be filed by companies that have sold securities without registration under the Securities Act of 1933. OrbiMed Partners II, L.P.’s submission of this form indicates that they have raised capital through a private offering.
OrbiMed Partners II, L.P. is a renowned healthcare-dedicated investment firm that manages over $18 billion in assets. The firm specializes in investing globally across the healthcare industry, from biopharmaceuticals to medical devices and healthcare services. With a team of over 100 employees located in offices around the world, OrbiMed is committed to providing capital and expertise to help healthcare companies innovate and grow. For more information about OrbiMed Partners II, L.P., visit their official website.
Form D is a notice of exempt offering of securities that is filed with the SEC. It is used to notify the commission of the sale of securities without registration under Regulation D of the Securities Act of 1933. This form includes basic information about the offering and the parties involved, providing transparency to investors and regulators about the details of the transaction.
Read More:
OrbiMed Partners II, L.P. Files Form D/A with the SEC
Leave a Reply